Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates

Go back to Madrigal Pharmaceuticals Reports Third-Quarter 2024 Financial Results and Provides Corporate Updates
(NASDAQ: MDGL) Delayed: 531.52 -2.88 (0.54%)
Previous Close $534.40    52 Week High $18.24 
Open $535.08    52 Week Low $6.60 
Day High $537.73    P/E N/A 
Day Low $526.65    EPS $0.00 
Volume 330,615